Rapid Protocol Enrollment in Osteosarcoma: a report from the Children’s Oncology Group

Ítems similars

• A Phase II Study of Eribulin in Recurrent or Refractory Osteosarcoma: a report from the Children’s Oncology Group
  per: Isakoff, Michael S., et al.
  Publicat: (2018)
• Factors Influencing Survival after Recurrence in Osteosarcoma: A Report from the Children’s Oncology Group.
  per: Spraker-Perlman, Holly L., et al.
  Publicat: (2018)
• Assessment of Extent of Surgical Resection of Primary High-Grade Osteosarcoma by Treating Institutions: A Report From the Children’s Oncology Group
  per: Morris, Carol D., et al.
  Publicat: (2016)
• Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward
  per: Lagmay, Joanne P., et al.
  Publicat: (2016)
• A Summary of the Osteosarcoma Banking Efforts: A Report from the Children’s Oncology Group and the QuadW Foundation
  per: Glover, Jason, et al.
  Publicat: (2014)